Cowen Inc’s AbbVie ABBV Stock Holding History

Cowen Inc’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-10,750	Closed	-$845K	–	447
2019 Q1	$866K	Buy	+10,750	New	+$879K	0.09%	124
2017 Q2	–	Sell	-2,000	Closed	-$130K	–	307
2017 Q1	$130K	Buy	+2,000	New	+$126K	0.01%	215
2015 Q4	–	Sell	-1,500	Closed	-$82K	–	295
2015 Q3	$82K	Sell	1,500 -34,624	-96%	-$2.25M	﹤0.01%	234
2015 Q2	$2.43M	Buy	36,124 +10,372	+40%	+$677K	0.15%	106
2015 Q1	$1.51M	Buy	+25,752	New	+$1.56M	0.12%	106
2014 Q4	–	Sell	-5,000	Closed	-$289K	–	230
2014 Q3	$289K	Buy	+5,000	New	+$278K	0.03%	235

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Cowen Inc's ABBV Position: Q2 2019 in Review

Cowen Inc sold out of AbbVie (ABBV) in Q2 2019, closing a stake of 10,750 shares — an estimated $845K sold.

Cowen Inc first reported a position in ABBV in Q3 2014 and held it in 6 quarters. The position peaked at $2.43M in Q2 2015. 2,021 funds tracked by Wall St. Rank hold ABBV as of Q2 2019.

Cowen Inc reported no remaining AbbVie position as of Q2 2019 after selling out during the quarter.
Cowen Inc sold 10,750 AbbVie shares in Q2 2019, an estimated $845K.
Cowen Inc first reported a position in AbbVie in Q3 2014 and held it in 6 quarters.
Cowen Inc's AbbVie position peaked at $2.43M in Q2 2015.
2,021 funds tracked by Wall St. Rank held AbbVie as of Q2 2019.

Based on Cowen Inc's 13F filing for Q2 2019, filed 14 Aug 2019.